In a column I wrote a couple years ago, I noted that, despite my fascination with the subject of psychology, I have only an amateur understanding of it. We can add artificial intelligence (AI) to the long list of things I’m not an expert on. I know what it is…
Discussion
The two main mouse models used to study myelin damage in multiple sclerosis (MS) each replicate important but distinct biological features of the disease — but both fall short of capturing its full biological complexity, a new study shows. The findings suggest that each of these two models may…
Discussion
Enrollment is half complete in an ongoing clinical study at Massachusetts General Hospital (MGH) testing whether a PET imaging tracer can reliably measure myelin damage in people with multiple sclerosis (MS). The Phase 1 study (NCT04699747) is recruiting about 60 people — healthy adults and MS patients — who…
Discussion
Dear family and friends, Over the years, I have wondered how my diagnosis of relapsing-remitting multiple sclerosis has impacted your worlds, as well. Just as I am unable to convey the impact of its collision with the life as I once knew, I imagine those words don’t necessarily come…
Discussion
Leaders in multiple sclerosis (MS) research and care are preparing to gather in Charlotte, North Carolina, for the Consortium of MS Centers (CMSC) annual meeting, with this year marking the organization’s 40th anniversary. Multiple Sclerosis News Today sat down with the consortium’s CEO, Kathleen Costello, to discuss the…
Get regular updates to your inbox.
